ROBERT A INGRAM Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT A INGRAM.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT A INGRAM. ROBERT A INGRAM is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in CREE INC ($CREE) and a Director in REGENERON PHARMACEUTICALS INC ($REGN) and a Director in Valeant Pharmaceuticals International, Inc. ($BVF) and a Director in Edwards Lifesciences Corp ($EW) and a Director in Novan, Inc. ($NOVN).

Over the past year ROBERT A INGRAM has been an insider in 2 companies. The total value of shares held by ROBERT A INGRAM in these companies amounts to $1,036,386.

ROBERT A INGRAM Director
Bausch Health Companies Inc.
Director
BIOCRYST PHARMACEUTICALS INC
Director
CREE, INC.
Director
Edwards Lifesciences Corp
Director
Novan, Inc.
Director
REGENERON PHARMACEUTICALS, INC.
$ 1036386 The total value of shares held by ROBERT A INGRAM
Insider Rank

ROBERT A INGRAM ranks 16,737 out of 350,000 insiders. Go to Insider Ranking to see more.

Companies in which ROBERT A INGRAM is an Insider

Bausch Health Companies Inc.

Trading Symbol: BVF
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 89,926 shares
Latest Transaction: Jan 04 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 21,060
Shares Sold: 0
Share Difference: +21,060
Value Difference: -$64,230

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT A INGRAM: Director
Holdings: 60,916 shares
Current Value: $345,394
Latest Transaction: May 14 2020
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 14x
Sell: 0x
Shares Bought: 70,082
Shares Sold: 0
Share Difference: +70,082
Value Difference: -$237,721

CREE, INC.

Trading Symbol: CREE
Industry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of ROBERT A INGRAM: Director
Holdings: 77,710 shares
Current Value: $2,171,217
Latest Transaction: Oct 18 2018
$CREE Market Capitalization: $2.75B
$CREE Previous Close: $27.94

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 14x
Sell: 0x
Shares Bought: 27,771
Shares Sold: 0
Share Difference: +27,771
Value Difference: -$425,992

Edwards Lifesciences Corp

Trading Symbol: EW
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of ROBERT A INGRAM: Director
Holdings: 32,367 shares
Current Value: $2,936,011
Latest Transaction: May 19 2015
$EW Market Capitalization: $19.41B
$EW Previous Close: $90.71

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Novan, Inc.

Trading Symbol: NOVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 169,777 shares
Current Value: $690,992
Latest Transaction: Aug 02 2019
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 139,777
Shares Sold: 0
Share Difference: +139,777
Value Difference: -$307,309

REGENERON PHARMACEUTICALS, INC.

Trading Symbol: REGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 1,500 shares
Current Value: $536,535
Latest Transaction: May 27 2015
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of ROBERT A INGRAM

Sentiment: All, BVF, BCRX, CREE, EW, NOVN, REGN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 14 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorOption ExerciseA5.4140,000216,40040,000
Mar 03 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA3.006,25018,75060,91654.7 K to 60.9 K (+11.43 %)
Mar 03 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA3.006,25018,75060,91654.7 K to 60.9 K (+11.43 %)
Dec 03 2019BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA2.856,57818,74754,66648.1 K to 54.7 K (+13.68 %)
Nov 18 2019BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorBuyP1.4520,00029,00048,08828.1 K to 48.1 K (+71.20 %)
Sep 04 2019BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA2.996,27018,74728,08821.8 K to 28.1 K (+28.74 %)
Aug 02 2019NOVNNovan, Inc.INGRAM ROBERT ALEXANDERDirectorOption ExerciseA2.6320,00052,60020,000

View all ROBERT A INGRAM insider transactions.